The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
about
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice.Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status.Bovine α-Lactalbumin Hydrolysates (α-LAH) Ameliorate Adipose Insulin Resistance and Inflammation in High-Fat Diet-Fed C57BL/6J Mice.
P2860
The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@ast
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@en
type
label
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@ast
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@en
prefLabel
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@ast
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@en
P2860
P1433
P1476
The CCR2 Inhibitor Propagerman ...... Non-Alcoholic Steatohepatitis.
@en
P2093
Anita M van den Hoek
Robert Kleemann
P2860
P304
P356
10.1371/JOURNAL.PONE.0169740
P407
P50
P577
2017-01-11T00:00:00Z